AABB News Flash - December 23, 2014

  Visit aabb.orgUnsubscribe to this Newsletter December 23, 2014

FDA Issues Statement on MSM Blood Donor Deferral Policy

In a statement released today, Food and Drug Administration Commissioner Margaret Hamburg announced the agency’s intention to issue a draft guidance recommending a proposed change to donor deferrals for men who have had sex with other men, or MSM.

AABB supports the change described in Commissioner Hamburg’s statement. AABB believes the change is supported by evidence and aligns the donor deferral period for MSM with criteria for other activities that may pose a similar risk for transfusion-transmissible infections.

Peter Marks, MD, PhD, deputy director of FDA’s Center for Biologics Evaluation and Research, acknowledged the blood community. “I just want to thank all of the blood collection establishments because they have been integral in helping to gather this data that has helped us move forward in this matter,” said Marks. “We look forward to continuing to work together as we look at our blood donor deferral policies.”

About AABB

AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership consists of nearly 2,000 institutions and 8,000 individuals, including physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. Members are located in more than 80 countries. For more information, visit www.aabb.org.


AABB, 8101 Glenbrook Road, Bethesda, MD 20814
Managing Editor:
Jerilyn Schweitzer

Copyright 2014 AABB. All rights reserved.